Exclusive

Publication

Byline

Location

Alamar Biosciences Launches EMTBR-Tau Immunoassay For Alzheimer's Disease

India, July 7 -- Alamar Biosciences, Inc. (ALMR), a commercial-stage proteomics company, announced on Tuesday the commercial launch of a multiplexed blood-based immunoassay for eMTBR-Tau, a biomarker ... Read More


U.S. Stocks Under Pressure Amid Tech Sector Pullback

India, July 7 -- Stocks have moved mostly lower during trading on Tuesday, giving back ground following the strength seen in the previous session. The major averages have all moved to the downside, wi... Read More


Rivian Automotive Stock Falls 13%

India, July 7 -- Rivian Automotive, Inc. (RIVN) stock fell 13.20 percent to $17.48, down $2.66 on Tuesday, from its previous close of $20.14, possibly after the electric vehicle maker announced a publ... Read More


Sompo Holdings To Buy Service Insurance Companies, Stock Rises

India, July 7 -- Tuesday, Sompo Holdings, Inc. (SMPNY.PK) announced an agreement to acquire Service Insurance Companies, a specialist in workers' compensation insurance. The financial terms of the dea... Read More


Alterity To Initiate Phase 3 Trial Of ATH434 In MSA Subsequent To Receipt Of EOP2 Minutes From FDA

India, July 7 -- Alterity Therapeutics Ltd. (ATHE), a clinical-stage biotechnology company, announced that it has received the U.S. Food and Drug Administration's meeting minutes from the End-of Phase... Read More


FDA Accepts Agios' SNDA For Mitapivat In Sickle Cell Disease With Nov '26 PDUFA Date; Stock Up

India, July 7 -- Agios Pharmaceuticals Inc. (AGIO), a commercial-stage biopharmaceutical company, on Tuesday announced that the U.S. Food and Drug Administration (FDA) has accepted under a priority re... Read More


Tvardi Therapeutics Stock Gains 42% Over Encouraging Data From TTI-109 Study

India, July 7 -- Shares of Tvardi Therapeutics, Inc. (TVRD) are climbing around 42 percent on Tuesday morning after the company announced results from its Phase 1 study of TTI-109, its next-generation... Read More


Agios Pharmaceuticals Stock Rises 12% After FDA Grants Priority Review For Sickle Cell Drug

India, July 7 -- Shares of Agios Pharmaceuticals, Inc. (AGIO) gained more than 12% on Tuesday morning after the U.S. Food and Drug Administration granted Priority Review to the company's supplemental ... Read More


Core AI Holdings Names Arie Goor CFO; Shares Up

India, July 7 -- On Tuesday, Core AI Holdings, Inc. (CHAI) announced the appointment of Arie Goor as its Chief Finance Officer, effective July 1. On the Nasdaq, the shares were trading 3.11 percent a... Read More


Global Markets Trade On A Volatile Note

India, July 7 -- Renewed volatility in the tech sector amidst worries about the hype surrounding artificial intelligence weighed on global market sentiment. The tech-heavy Nasdaq Composite is trading ... Read More